Pietro Familiari

Pietro Familiari

Auto-generated profile, based on publicly available information

Pietro Familiari

Digestive Endoscopy Unit, Agostino Gemelli University Hospital, Universita Cattolica del Sacro Cuore, Rome, Italy

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2019 in JAMA
Verified
Journal Article
Open access
PDF file
FPFraukje A. Ponds
Fraukje A. Ponds
PFPaul Fockens
Paul Fockens
ALAaltje Lei
Aaltje Lei
HNHorst Neuhaus
Horst Neuhaus
TBTorsten Beyna
Torsten Beyna
ABAlbert J. Bredenoord
Albert J. Bredenoord
Quiz Ref ID Achalasia is an esophageal motility disorder characterized by absent peristalsis in the esophageal body and impaired relaxation of the lower esophageal sphincter (LES), which hampers esophageal emptying, that typically results in symptoms of dysphagia, regurgitation of food, chest pain, and weight loss.1 Treatment for patients with achalasia involves medical, endoscopic, and surgical options. Endoscopic pneumatic dilation is the most commonly performed treatment worldwide for patients with achalasia. The procedure is minimally invasive and the long-term therapeutic rate of success, defined as a reduction of the Eckardt score to less than or equal to 3 and the absence of the need for re-treatment, is 50% to 85%.2-5 Approximately 1% to 3% of endoscopic pneumatic dilation procedures are complicated by a perforation.2,6,7 Laparoscopic Heller myotomy combined with an antireflux procedure offers a more permanent solution for patients with achalasia, with success rates of 80% to 90%.2,3,6 However, this technique is considerably more invasive and can be associated with severe complications, including transmural perforation (4%-10%), bleeding, or infection, and, therefore, is generally considered as treatment for patients who do not respond to pneumatic dilation.6

22 August 2016 in Endoscopy
Verified
Journal Article
Closed access
PDF file
RBRaf Bisschops
Raf Bisschops
MAMiguel Areia
Miguel Areia
ECEmmanuel Coron
Emmanuel Coron
DDDaniela Dobru
Daniela Dobru
BKBernd Kaskas
Bernd Kaskas
MRMatthew D. Rutter
Matthew D. Rutter

30 April 2015 in Gut
Verified
Journal Article
Closed access
PDF file
YWYuki B Werner
Yuki B Werner
GCGuido Costamagna
Guido Costamagna
LSLee L Swanström
Lee L Swanström
DRDaniel von Renteln
Daniel von Renteln
PFPietro Familiari
Pietro Familiari
TRThomas Rösch
Thomas Rösch
Background The recently developed technique for peroral endoscopic myotomy (POEM) has been shown to be effective in several short-term studies. Longer term outcome data are largely non-existent. Objective To systematically report clinical outcome with a minimum post-POEM follow-up of 2 years. Design All patients treated consecutively by POEM for achalasia at three centres were retrospectively analysed, with a minimum follow-up of 2 years. The main outcome was the rate of POEM failures (Eckardt score >3) related to follow-up time. Results Of 85 patients treated, five (5.9%) cases were excluded due to protocol violation or loss to follow-up; the remaining 80 patients (mean age 44.9 years, 54% men) were followed clinically for 29 months (range 24–41). Initial clinical response was observed in 77 cases (96.3%). Clinical recurrences (later failures) were seen in a further 14 cases (17.7%), accounting for a total failure rate of 21.5%. In a multivariate analysis, age and endoscopic reflux signs were independent predictors of treatment success. Of the 17 failures, eight were among the first 10 cases treated in the participating centres. Reflux-associated sequelae included one case of a severe reflux-associated stricture requiring dilatation, and two patients with minor transient Eckardt score elevations curable by proton pump inhibitor (PPI) treatment. Endoscopic signs of reflux oesophagitis, mostly Los Angeles grade A/B, were seen in 37.5% (37/72) at the 2-year control. Conclusions In this multicentre retrospective analysis, a high initial success rate of POEM is followed by a mid-term recurrence rate of 18%. Reflux oesophagitis, albeit mild, is frequent and should probably be treated by regular low-dose PPI therapy. Trial registration number NCT 01405417 (UKE study).

7 March 2006 in Endoscopy
Verified
Journal Article
Closed access
PDF file
Guido CostamagnaGuido Costamagna
Guido Costamagna
MBM. Bulajic
M. Bulajic
ATA. Tringali
A. Tringali
MPM. Pandolfi
M. Pandolfi
AGArmando Gabbrielli
Armando Gabbrielli
MMMassimiliano Mutignani
Massimiliano Mutignani
Background and Study Aims: Dominant pancreatic duct strictures located in the head of the pancreas in patients with severe chronic pancreatitis are often managed by endoscopic placement of a single plastic stent. Patients with refractory strictures after prolonged stenting require repeated stent replacement or surgical pancreaticojejunostomy. Placement of multiple plastic stents has proved effective in managing postoperative biliary strictures. The aim of this study was to investigate the feasibility, efficacy, and long-term results of multiple stenting of refractory pancreatic strictures in severe chronic pancreatitis. Patients and Methods: 19 patients with severe chronic pancreatitis (16 men, three women; mean age 45 years) and with a single pancreatic stent through a refractory dominant stricture in the pancreatic head underwent the following protocol: (i) removal of the single pancreatic stent; (ii) balloon dilation of the stricture; (iii) insertion of the maximum number of stents allowed by the stricture tightness and the pancreatic duct diameter; and (iv) removal of stents after 6 to 12 months. Results: The median number of stents placed through the major or minor papilla was 3, with diameters ranging from 8.5 to 11.5 Fr and length from 4 to 7 cm. Only one patient (5.5 %) had persistent stricture after multiple stenting. During a mean follow-up of 38 months after removal, 84 % of patients were asymptomatic, and 10.5 % had symptomatic stricture recurrence. No major complications were recorded. Conclusion: Endoscopic multiple stenting of dominant pancreatic duct strictures in chronic pancreatitis is a feasible and safe technique. Multiple pancreatic stenting is promising in obtaining persistent stricture dilation on long-term follow-up in the setting of severe chronic pancreatitis.

22 May 2007 in Endoscopy
Verified
Journal Article
Closed access
PDF file
MMMassimiliano Mutignani
Massimiliano Mutignani
ATA. Tringali
A. Tringali
SSS. G. Shah
S. G. Shah
VPV. Perri
V. Perri
PFP. Familiari
P. Familiari
GCG. Costamagna
G. Costamagna
Background and study aims: Self-expandable metal stents (SEMS) are an effective palliative treatment for malignant biliary and duodenal strictures. Combined biliary and duodenal stenting remains a technical challenge, however. The aim of this study was to evaluate the technical feasibility of an endoscopic approach to double stenting of malignant biliary and duodenal strictures. Patients and methods: Consecutive patients referred for palliative gastroduodenal and biliary stenting were followed up prospectively. Patients’ demographic characteristics, the site and nature of the strictures, success rates, complications, and survival time were recorded. Results: A total of 64 patients underwent double stenting. In 46 patients, biliary obstruction occurred before the onset of duodenal obstruction (by a median of 107 days) (group 1); in 14 patients, biliary obstruction occurred concurrently with duodenal obstruction (group 2); and in four patients the duodenal obstruction preceded the biliary obstruction (by a median of 121 days) (group 3). The duodenal strictures were proximal to the papilla in 31 patients, adjacent to the papilla in 25 patients and distal to the papilla in eight patients. The majority of biliary strictures were in the middle or distal third of the bile duct (in 52/64 patients). Duodenal SEMS were successfully deployed in all patients. Combined endoscopic stenting was successful in 100 % of patients in group 1, 86 % of patients in group 2, and in 100 % of patients in group 3. Taking the three groups together, early complications occurred in 6 % of patients and late complications occurred in 16 % of patients. The overall median survival after combined stenting was 81 days (range 2 - 447 days). Conclusions: Combined endoscopic biliary and duodenal SEMS insertion is safe and effective for palliation in malignant biliary and duodenal obstruction. Biliary stenting through the mesh of the duodenal SEMS is technically feasible and has a high success rate.

4 May 2017 in Endoscopy
Verified
Journal Article
Closed access
PDF file
VKVivek Kumbhari
Vivek Kumbhari
PFPietro Familiari
Pietro Familiari
NBNiels Christian Bjerregaard
Niels Christian Bjerregaard
MPMathieu Pioche
Mathieu Pioche
EJEdward Jones
Edward Jones
MKMouen A. Khashab
Mouen A. Khashab
Background and study aims The variables associated with gastroesophageal reflux (GER) after peroral endoscopic myotomy (POEM) are largely unknown. This study aimed to: 1) identify the prevalence of reflux esophagitis and asymptomatic GER in patients who underwent POEM, and 2) evaluate patient and intraprocedural variables associated with post-POEM GER. Patients and methods All patients who underwent POEM and subsequent objective testing for GER (pH study with or without upper gastrointestinal [GI] endoscopy) at seven tertiary academic centers (one Asian, two US, four European) were included. Patients were divided into two groups: 1) DeMeester score ≥ 14.72 (cases) and 2) DeMeester score of < 14.72 (controls). Asymptomatic GER was defined as a patient with a DeMeester score ≥ 14.72 who was not consuming proton pump inhibitor (PPI). Results A total of 282 patients (female 48.2 %, Caucasian 84.8 %; mean body mass index 24.1 kg/m2) were included. Clinical success was achieved in 94.3 % of patients. GER evaluation was completed after a median follow-up of 12 months (interquartile range 10 – 24 months). A DeMeester score of ≥ 14.72 was seen in 57.8 % of patients. Multivariable analysis revealed female sex to be the only independent association (odds ratio 1.69, 95 % confidence interval 1.04 – 2.74) with post-POEM GER. No intraprocedural variables were associated with GER. Upper GI endoscopy was available in 233 patients, 54 (23.2 %) of whom were noted to have reflux esophagitis (majority Los Angeles Grade A or B). GER was asymptomatic in 60.1 %. Conclusion Post-POEM GER was seen in the majority of patients. No intraprocedural variables were identified to allow for potential alteration in procedural technique. * Co-first authors